반응 #64293
ord-55b34c143a0e4a11a9b1a408b5d9a37c
반응 방정식
반응물
시약
반응 조건
후처리
- 1기타followed by evaporation of the solvent
- 2workup.WAITAfter a few minutes at 0° C.
- 3기타the solvent was evaporated
- 4기타all the protecting groups removed
- 5workup.ADDITIONby treating the crude
- 6기타reaction mixture with TFA/water for 1 hour at room temperature
- 7기타The solvents were evaporated
- 8workup.DISSOLUTIONthe crude product dissolved in MeOH
- 9기타precipitated in ether
- 10기타Further purification
실험 절차
1 equivalent of 7-amino-3-[2-(3,4-dihydroxyphenyl)-1,3,4-thiadiazol-5-ylthiomethyl]ceph-3-em-4-carboxylic acid was silylated with 4 equivalents of bistrimethylsilylacetamide in anhydrous dichloromethane at room temperature for three hours. To this solution, cooled to 0° C. under argon, was added 1 equivalent of 2-[(Z)-ethoxyimino-2-(tritylaminothiazol-4-yl) acetic acid chloride (prepared from the corresponding acid (1 equivalent), 1 equivalent PCl5 and 1 equivalent TEA in dichloromethane at 0° C. for 2 hours followed by evaporation of the solvent and all POCl3, and redissolution in dichloromethane). After a few minutes at 0° C., the solvent was evaporated, and all the protecting groups removed by treating the crude reaction mixture with TFA/water for 1 hour at room temperature. The solvents were evaporated and the crude product dissolved in MeOH and precipitated in ether. Further purification was achieved by MPLC, to yield the title compound (7%), NMR (DMSOd6, AcOD, TFA), 1.25 (t,3H); 3.7 (m,2H); 4.2 and 4.25 (2d,2H); 4.4 (q,2H); 5.15 (d,1H); 5.75 (d,1H); 6.85 (d,1H); 7 (s,1H); 7.15 (d,1H); 7.3 (s,1H).